Eric Haines

1.2k total citations
14 papers, 282 citations indexed

About

Eric Haines is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Eric Haines has authored 14 papers receiving a total of 282 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 9 papers in Oncology and 5 papers in Immunology. Recurrent topics in Eric Haines's work include Immunotherapy and Immune Responses (4 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and Cancer Cells and Metastasis (3 papers). Eric Haines is often cited by papers focused on Immunotherapy and Immune Responses (4 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and Cancer Cells and Metastasis (3 papers). Eric Haines collaborates with scholars based in United States, Canada and Italy. Eric Haines's co-authors include Audrey Claing, Caroline Saucier, Eftihia Cocolakis, Suhad Ali, Jean‐Jacques Lebrun, Joanne Ho, Meiou Dai, Ting Chen, Kwok‐Kin Wong and Zhao Chen and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and Molecular and Cellular Biology.

In The Last Decade

Eric Haines

12 papers receiving 275 citations

Peers

Eric Haines

ONCOL

PRM

IMMUN

Hannah Dry United Kingdom

Cristina Chiriaco Italy

Woody Han United States

Cheng‐Hao Chuang Taiwan

Sourik S. Ganguly United States

Melanie Dujka United States

Luigi Alfano Italy

Matthew A. Whitman United States

Anita Welk Germany

Les Brail United States

Hannah Dry United Kingdom

Eric Haines

143 ×0.9

166 ×1.2

ONCOL

45 ×1.0

PRM

29 ×0.8

IMMUN

20 ×0.6

Citations per year, relative to Eric Haines Eric Haines (= 1×) peers Hannah Dry

Countries citing papers authored by Eric Haines

Since Specialization

Citations

This map shows the geographic impact of Eric Haines's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric Haines with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric Haines more than expected).

Fields of papers citing papers by Eric Haines

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric Haines. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric Haines. The network helps show where Eric Haines may publish in the future.

Co-authorship network of co-authors of Eric Haines

This figure shows the co-authorship network connecting the top 25 collaborators of Eric Haines. A scholar is included among the top collaborators of Eric Haines based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric Haines. Eric Haines is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Rigby, Michael, Gavin Bennett, Liuhong Chen, et al.. (2022). BT8009; A Nectin-4 Targeting Bicycle Toxin Conjugate for Treatment of Solid Tumors. Molecular Cancer Therapeutics. 21(12). 1747–1756. 41 indexed citations

Haines, Eric, Yuki Nishida, Weiguo Zhang, et al.. (2021). DNA-PK inhibitor peposertib enhances p53-dependent cytotoxicity of DNA double-strand break inducing therapy in acute leukemia. Scientific Reports. 11(1). 12148–12148. 23 indexed citations

Hurov, Kristen E., Johanna Lahdenranta, Punit Upadhyaya, et al.. (2021). BT7480, a novel fully synthetic Bicycle tumor-targeted immune cell agonist™ (Bicycle TICA™) induces tumor localized CD137 agonism. Journal for ImmunoTherapy of Cancer. 9(11). e002883–e002883. 25 indexed citations

Dufort, Fay J., Gemma Mudd, Eric Haines, et al.. (2021). 789 Generation of a Bicycle NK-TICA™, a novel NK cell engaging molecule to enhance targeted tumor cytotoxicity. Regular and Young Investigator Award Abstracts. A824–A824.

Hurov, Kristen E., Johanna Lahdenranta, Punit Upadhyaya, et al.. (2021). Abstract 1728: Nectin-4-dependent immune cell stimulation and anti-tumor efficacy by BT7480, a Nectin-4/CD137 Bicycle®tumor-targeted immune cell agonist (TICA™). Cancer Research. 81(13_Supplement). 1728–1728. 1 indexed citations

Hurov, Kristen E., Johanna Lahdenranta, Gemma Mudd, et al.. (2020). 700 EphA2/CD137 Bicycle tumor-targeted immune cell agonists (TICAs^TM) induce tumor regressions, immunogenic memory, and reprogramming of the tumor immune microenvironment. SHILAP Revista de lepidopterología. A420.2–A421. 1 indexed citations

Upadhyaya, Punit, Kristen E. Hurov, Jun Ma, et al.. (2020). 706 BT7480, a fully synthetic tumor-targeted immune cell agonist (TICA™) induces tumor localized CD137 agonism and modulation of tumor immune microenvironment. Regular and Young Investigator Award Abstracts. A424.1–A424. 2 indexed citations

Rigby, Michael, Gavin Bennett, Liuhong Chen, et al.. (2019). Abstract C061: BT8009, a Bicycle Toxin Conjugate targeting Nectin-4, shows target selectivity, and efficacy in preclinical large and small tumor models. Molecular Cancer Therapeutics. 18(12_Supplement). C061–C061. 8 indexed citations

Haines, Eric, Astrid Zimmermann, Frank T. Zenke, Andree Blaukat, & Lyubomir T. Vassilev. (2018). Abstract 4830: Selective DNA-PK inhibitor, M3814, boosts p53 apoptotic response to DNA double strand breaks and effectively kills acute leukemia cells: Implications for AML therapy. Cancer Research. 78(13_Supplement). 4830–4830. 1 indexed citations

10.

Haines, Eric, Ting Chen, Naveen Kommajosyula, et al.. (2018). Palbociclib resistance confers dependence on an FGFR-MAP kinase-mTOR-driven pathway inKRAS-mutant non-small cell lung cancer. Oncotarget. 9(60). 31572–31589. 37 indexed citations

11.

Haines, Eric, et al.. (2015). The small GTPase ADP-Ribosylation Factor 1 mediates the sensitivity of triple negative breast cancer cells to EGFR tyrosine kinase inhibitors. Cancer Biology & Therapy. 16(10). 1535–1547. 21 indexed citations

12.

Haines, Eric, Caroline Saucier, & Audrey Claing. (2014). The Adaptor Proteins p66Shc and Grb2 Regulate the Activation of the GTPases ARF1 and ARF6 in Invasive Breast Cancer Cells. Journal of Biological Chemistry. 289(9). 5687–5703. 43 indexed citations

13.

Haines, Eric, Parham Minoo, Manuela Campiglio, et al.. (2009). Tyrosine Phosphorylation of Grb2: Role in Prolactin/Epidermal Growth Factor Cross Talk in Mammary Epithelial Cell Growth and Differentiation. Molecular and Cellular Biology. 29(10). 2505–2520. 29 indexed citations

14.

Cocolakis, Eftihia, Meiou Dai, Joanne Ho, et al.. (2007). Smad Signaling Antagonizes STAT5-mediated Gene Transcription and Mammary Epithelial Cell Differentiation. Journal of Biological Chemistry. 283(3). 1293–1307. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact